Asklepios: Notification according to Section 27a WpHG to RHÖN-KLINIKUM AG
By publishing the voting rights notification dated 22 May 2017, Asklepios Kliniken disclosed that it had exceeded the 25% threshold with a share of 25.10% in RHÖN KLINIKUM AG.
With regard to the aims underlying the purchase of the voting rights, RHÖN-KLINIKUM AG was notified on 14 June 2017 in accordance with Section 27a (1) sentences 1 and 3 of the German Securities Trading Act (WpHG) that Asklepios Kliniken Verwaltungsgesellschaft mbH
- sees the investment in the company as a long-term strategic investment;
- possibly intends to purchase or otherwise obtain additional voting rights depending on the share price and the general performance of its company within the next twelve months;
- will seek appropriate representation on the Supervisory Board and intends to use its voting rights accordingly;
- does not currently intend to achieve a material change in the company’s capital structure, especially with regard to the ratio of own funds and external funds or the dividend policy.
Regarding the origin of the funds used to acquire the voting shares, RHÖN-KLINIKUM AG was also informed according to Section 27a (1) sentences 1 and 4 WpHG that the acquisition was financed with own funds.
Link to DGAP voting rights notification:
ehttp://www.dgap.de/dgap/News/pvr/rhoenklinikum-veroeffentlichung-gemaess-abs-wphg-mit-demziel-der-europaweiten-verbreitung/?newsID=1011171
